“We want to create services and businesses that contribute to realising a healthy lifestyle centered on microbiota.”
Resident flora, which has pioneered the frontier in the field of life science, has been said to have a great effect on human health. Dynamically understanding the microbiota does not only lead to the discovery of diseases or treatments, but it also unravels presymptomatic diseases.
Currently, we are conducting an analysis by utilizing our original database and metagenome, metatranscriptome or metabolome data, which can be obtained from a next generation sequencer.
Also, the object for analysis is not only resident flora data, it applies to statistical approaches or machine learning by the combination of data gained from the unique sensor.
We believe that our development may become an important technology, which will estimate the cause and effect of the relationship of unexplained phenomenon and give a new meaning to the current microbiome.
It is estimated that there are more than 1000 strains of bacteria in human intestines. The whole community of bacteria is called microbiota. It has been reported that the function of the gut microbiota is related to various health conditions of humans including obesity, colon cancer and mental illness. Dynamically assessing and understanding various changes in gut microbiota will lead to the discovery, prevention and treatment of these diseases. However, it is very difficult to assess the gut microbiota in which a wide variety of bacteria exist, and the whole picture is unknown.
New Energy and Industrial Technology Development Organization (NEDO), Japan Microbiome Consortium (JMBC)